236. Pseudohypoparathyroidism Disease details / Clinical trials / Drug dev / DR info

Clinical trials : 3 /  Drugs : 3 - (DrugBank : 2) / Drug target genes : 18 - Drug target pathways : 23

Pseudohypoparathyroidism and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability
IDDiseases (Sorted by drug repositionability)
236Pseudohypoparathyroidism
299Cystic fibrosis
63Idiopathic thrombocytopenic purpura
246Methylmalonic acidemia
226Interstitial cystitis with Hunners ulcer
265Lipodystrophy
46Malignant rheumatoid arthritis
13Multiple sclerosis/Neuromyelitis optica
78Hypopituitarism
96Crohn disease
2Amyotrophic lateral sclerosis
21Mitochondrial disease
97Ulcerative colitis
6Parkinson disease
107Juvenile idiopathic arthritis
162Pemphigoid
56Behcet disease
271Ankylosing spondylitis
50Dermatomyositis
191Werner syndrome